|
    
|
|
Technology
The market
for aquaculture products has exhibited strong growth over the
last 10 years. We anticipate that trend will continue, certainly
in the near term, as the global demand for lower cost, quality
seafoods expands. To meet that growing demand and to maintain
their price competitiveness producers will increasingly turn to
technology as they look to increase productivity.
Aqua Bounty
has identified life science strategies that have the potential
to improve the health and productivity of important aquaculture
species, using a variety of biotechnologies for our current and
pipeline products. These include
- gene and
protein sequencing,
- expression
of gene repression factors,
- receptor
blocking technologies,
- transgenesis,
and
- quantitative
polymerase chain reaction (qPCR).
The company
is building a portfolio of products to address critical production
constraints in the most popular farmed species, focusing initially
on shrimp, salmon and trout.
Bacterial
and viral diseases, which are pervasive in nature, represent a
major constraint in all forms of aquaculture. Aqua Bounty has,
or is developing, effective solutions built around improving the
health of the farmed fish and shellfish to augment yields. An
integrated suite of diagnostic, immunostimulant and therapeutic
products for shrimp are currently on the market in selected locations
or are in pre-market trials preparatory to launch. Parallel products
for finfish are in the development stage.
The AquaAdvantage™
broodstock program is based upon a single, highly specific molecular
modification in fish that results in more rapid growth and hence
reduced cycle times; which in turn can increase the frequency
of farmers’ harvests and reduce the impact of fish farming
on the environment.
|
